Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases
Agata Mostkowska, Guy Rousseau, Noël J-M Raynal
doi: https://doi.org/10.1101/2023.09.22.23295633
Agata Mostkowska
1Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Quebec, H3T 1C5, Canada
Guy Rousseau
1Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Quebec, H3T 1C5, Canada
Noël J-M Raynal
1Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Quebec, H3T 1C5, Canada
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present work are contained in the manuscript
Posted September 25, 2023.
Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases
Agata Mostkowska, Guy Rousseau, Noël J-M Raynal
medRxiv 2023.09.22.23295633; doi: https://doi.org/10.1101/2023.09.22.23295633
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2637)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12211)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4087)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2646)
- Health Policy (1003)
- Hematology (362)
- HIV/AIDS (850)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3862)
- Nursing (209)
- Nutrition (577)
- Oncology (2022)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6516)
- Radiology and Imaging (1398)
- Respiratory Medicine (871)
- Rheumatology (404)
- Sports Medicine (342)
- Surgery (444)
- Toxicology (52)
- Transplantation (185)
- Urology (165)